北京时间2024年10月2日,生命科学公司伊鲁米纳(ILMN)股价在当日盘中大涨5.82%,报收于135.60美元,引发市场广泛关注。
伊鲁米纳是一家专注于生命科学和临床实验室应用的公司,主要提供分析遗传物质的工具和服务。公司90%以上的收入来自测序仪器、耗材和服务,其高通量技术使人类和其他大型生物的全基因组测序成为可能。公司当前市值约为280亿美元。
尽管并无直接消息指明伊鲁米纳股价今日暴涨的原因,但分析人士普遍认为,公司优异的财务数据和有利的行业环境或许是导致股价走高的主要推手。该公司最新财报显示,营收达到11.12亿美元,毛利达7.21亿美元,尽管净利润为负但整体业绩表现良好。同时,生命科学行业当日整体上涨0.5%,公司股价自三个月前以来已累计大涨超过20%,反映了市场对伊鲁米纳长期前景的看好。不过,股价短期内能否持续上涨仍有待进一步观察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.